摘要
目的:分析我院降糖药的使用情况。方法:调取我院计算机信息管理系统2009～2011年的降糖药物销售记录进行统计分析。结果:我院降糖药销售金额逐年上升,且口服降糖药的使用量大于胰岛素制剂。DDDs排名前2位的药品分别为瑞格列奈片(孚来迪)、精蛋白生物合成人胰岛素注射液(诺和灵),其次为α-葡萄糖苷酸抑制剂、磺酰脲类、中成药类以及双胍类。结论:我院降糖药的使用基本上遵循了安全、有效和经济的用药原则。
Objective：To analyze the use condition of antihyperglydemic drugs in our hospital. Methods：The sales records of antihyperglycemic drugs from 2009 to 2011 were analyzed.Results： The sales amount increased year after year, and the amount of oral drugs was larger than that of insulin. The first two rankings of DDDs were repaglinide tablets and isophane protamine biosynthetic human insulin injection, followed by oL-glycosidase acid inhibitors, sulfonylurea, traditional Chinese medicine and biguanides. Conclusion： The use of antihyperglycemic drugs in our hospital mainly follows the principle of safe, effective and economic.
出处
《北方药学》
2012年第3期89-89,108,共2页
Journal of North Pharmacy
关键词
降糖药
糖尿病
用药分析
Antihyperglycemic drugs Diabetes Analysis of medication
